Skip to evidence report

ASPC.adipocyte_capillary_interface: Studies — page 2

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,040 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1,001–2,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for ASPC.adipocyte_capillary_interface
#Trait / studyIndividual trait IDMean IC score
1001T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 106)GCST903209254.53
1002Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T34ECGA0000344.52
1003LAMA4/NID1 ratioGCST903152724.52
1004LDLR levelsGCST901793464.52
1005IGFBP4/OGN ratioGCST903151344.52
1006C1QL2 levelsGCST904684874.51
1007XRCC4 levelsGCST904710854.51
1008Hemorrhoids | circulatory systemUKBB000003254.51
1009Operation code - coronary angioplasty (ptca) +/- stent | OperationsUKBB000005554.50
1010IDP dMRI ProbtrackX OD str rGCST900044744.50
1011COL6A3 levelsGCST904688214.50
1012ANGPT2 levelsGCST904683014.49
1013Diarrhoea and gastroenteritis of presumed infectious originFING000004204.49
1014Triglyceride to HDL cholesterol ratioGCST902959514.48
1015DPP6/SEZ6L ratioGCST903145444.48
1016FEV1/FVC ratio | Other measurementUKBB000002454.48
1017IDP dMRI ProbtrackX L3 fmiGCST900043114.47
1018Diastolic blood pressure, combined automated + manual reading | Cardiovascular measurementUKBB000001764.47
1019rfMRI connectivity (ICA100 edge 399)GCST900052524.47
1020wg lh intensity-contrast parsorbitalisGCST900038104.46
1021BA-exvivo lh volume BA3bGCST900028384.46
1022Diastolic blood pressure, combined automated + manual reading | Cardiovascular measurementUKBB000001774.46
1023IDP T1 FAST ROIs L cerebellum VIIIbGCST900025814.46
1024Benign mammary dysplasiaFING000001514.46
1025Comorbidity of gastric and duodenal ulcersGCST902709294.45
1026Childhood maltreatmentGCST905518444.45
1027Autorefraction - 3mm cylindrical power (right) | EyesightUKBB000000634.44
1028IGBP1 levelsGCST904695214.44
1029Spinal stenosis | musculoskeletalUKBB000007924.44
1030aparc-DKTatlas lh area caudalmiddlefrontalGCST900032364.44
1031Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T33ECGU0000334.43
1032Systolic blood pressureGCST904727804.43
1033FABP5 levelsGCST904691774.43
1034aparc-Desikan rh area cuneusGCST900031114.42
1035Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T420ECGA0004204.42
1036Optic cup areaGCST0041374.42
1037Systolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000008094.41
1038Tonsillectomy and adenotomyFING000013674.41
1039T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 115)GCST903206784.40
1040Ischemic heart disease (PheCode 411)GCST904759294.40
1041Diastolic blood pressure, automated reading | Blood pressureUKBB000001734.40
1042CCN5/IGFBP6 ratioGCST903137234.40
1043aparc-DKTatlas lh volume parsopercularisGCST900028784.40
1044CA2/TGM2 ratioGCST903135824.39
1045AGER levelsGCST900120544.39
1046PON2/PON3 ratioGCST903157034.38
1047ENPP7 levelsGCST904691184.38
1048PON3 levelsGCST904702874.38
1049Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T375ECGU0003754.38
1050IDP dMRI TBSS MD Posterior thalamic radiation LGCST900040564.38
1051Cerebrospinal fluid 3-hydroxy-2-ethylpropionate levelsGCST903179644.37
1052FHIT/PARK7 ratioGCST903148214.37
1053DLK1/PIK3IP1 ratioGCST903144924.37
1054Glaucoma | sense organsUKBB000002874.36
1055IDP dMRI TBSS L3 Sagittal stratum LGCST900042024.36
1056aparc-a2009s rh area G-pariet-inf-AngularGCST900033954.36
1057PTPN1/TDRKH ratioGCST903157454.35
1058wg lh intensity-contrast transversetemporalGCST900038254.35
1059Metabolic disorder, other/unspecifiedFING000008154.35
1060FGFR2 levelsGCST904692334.34
1061aparc-DKTatlas lh volume lingualGCST900028734.34
1062Triacylglycerol_47:4_[M+NH4]1+ levelsGCST900603914.34
1063Benign lipomatous neoplasm of skin and subcutaneous tissue of trunkFING000001504.33
1064Physical activity (Total log acceleration 8am-10am)GCST900614134.33
1065Inguinal hernia, bilateralFING000006824.31
1066MIF/SUSD2 ratioGCST903154524.31
1067Hypermetropia (PheCode 367.8)GCST904758824.31
1068Disorders of breastFING000004374.31
1069Chronic ischaemic heart disease | Ischaemic heart diseasesUKBB000001374.30
1070Left-hemisphere dorsal attention network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903026964.29
1071Cholesteryl ester (16:2) levelsGCST900246284.29
1072Diastolic blood pressureGCST903016984.29
1073Systolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000008084.29
1074Premature beats (PheCode 427.6)GCST904759774.28
1075IDP dMRI ProbtrackX L2 ar lGCST900042734.28
1076Cardiovascular diseaseGCST900860574.28
1077Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T29ECGU0000294.28
1078BA-exvivo rh thickness BA4aGCST900035314.27
1079IDP dMRI TBSS L2 Cingulum hippocampus LGCST900041604.27
1080aparc-a2009s lh volume S-postcentralGCST900029914.27
1081Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T411ECGA0004114.27
1082Cataract (PheCode 366)GCST900437854.26
1083aparc-Desikan lh thickness paracentralGCST900034614.25
1084DNAJA2/HPCAL1 ratioGCST903145034.24
1085Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T366ECGU0003664.24
1086ITGBL1 levelsGCST904696484.24
1087Haemorrhoids | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classifiedUKBB000002944.24
1088T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 85)GCST903209044.23
1089NPY levelsGCST904700814.23
1090QC dMRI-to-T1 linear alignment discrepancyGCST900063514.23
1091Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T412ECGA0004124.22
1092Retinal detachments and breaksFING000012604.22
1093T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78)GCST903208974.22
1094CLK2 levelsGCST902409754.22
1095DTI TBSS L3 Posterior limb of internal capsule RGCST903845424.22
1096TNFRSF4/TNFRSF9 ratioGCST903159394.22
1097Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T24ECGU0000244.21
1098Systolic blood pressureGCST903102944.20
1099APOA2 levelsGCST904683324.20
1100PolyarthrosisFING000011814.19
1101BMPER levelsGCST904684554.19
1102Volume of right whole amygdalaGCST904750544.19
1103IDP dMRI ProbtrackX L1 ilf rGCST900042614.18
1104NRP1 levelsGCST904700854.18
1105Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T369ECGU0003694.17
1106GPD1 levelsGCST904693884.17
1107Other chronic ischemic heart disease, unspecified | circulatory systemUKBB000006034.16
1108Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T419ECGA0004194.16
1109DTI TBSS L3 Cingulum hippocampus RGCST903845604.15
1110Left-hemisphere control network to thalamus white-matter structural connectivityGCST903027524.15
1111NEO1 levelsGCST904700294.15
1112CR2/TNFRSF13B ratioGCST903142254.14
1113Breast cancerGCST0049884.14
1114Osteoarthrosis NOS | musculoskeletalUKBB000005974.14
1115IFIH1 levelsGCST904236894.14
1116Volume of left cortical nucleusGCST904749644.13
1117APEX1/LSP1 ratioGCST903133074.13
1118Volume of left whole amygdalaGCST904749884.12
1119CFHR4 levelsGCST900190454.12
1120SPARCL1 levelsGCST904707174.12
1121Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T44ECGU0000444.11
1122Left ventricular end systole anterolateral wall thicknessGCST902785114.11
1123T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 80)GCST903206434.11
1124ERP44 levelsGCST904691504.11
1125Kidney transplant statusFING000007104.11
1126DNAJB1/METAP2 ratioGCST903145094.10
1127IDP dMRI ProbtrackX FA str lGCST900039484.10
1128Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T235ECGA0002354.10
1129PDGFB/SPARC ratioGCST903156284.10
1130PTPN6/SNAP23 ratioGCST903157474.10
1131IFNGR2 levelsGCST904695144.10
1132Spontaneous coronary artery dissectionGCST902458784.10
1133Lactose intolerance, other/unspecifiedFING000007124.09
1134Treatment/medication code - co-codamol | MedicationsUKBB000008454.09
1135aparc-Desikan rh volume parsopercularisGCST900028184.08
1136DTI TBSS L2 Uncinate fasciculus LGCST903845214.08
1137Operation code - wisdom teeth surgery | OperationsUKBB000005694.08
1138Olsenella C abundance in stoolGCST900324934.08
1139Disorders of musclesFING000004444.08
1140Volume of right lateral nucleusGCST904750344.07
1141aparc-a2009s lh thickness S-intrapariet+P-transGCST900036584.07
1142Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T365ECGU0003654.07
1143NCR1 levelsGCST900901534.07
1144SnoringGCST0097634.07
1145Ischaemic heart disease, wide definitionFING000007034.05
1146CLUL1 levelsGCST904687924.05
1147Osteopenia or other disorder of bone and cartilage (PheCode 743.9)GCST904762614.05
1148T1 FreeSurfer aseg Left-Inf-Lat-VentGCST903841404.05
1149aparc-DKTatlas rh volume precentralGCST900029154.04
1150Systolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000008054.04
1151ANGPTL3/TFPI ratioGCST903132704.04
1152IDP dMRI TBSS MD Cingulum cingulate gyrus RGCST900040614.04
1153BCAN/DPP6 ratioGCST903134784.03
1154Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T399ECGA0003994.03
1155CDH2/CDHR2 ratioGCST903139504.03
1156Systolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000008044.03
1157Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T367ECGU0003674.02
1158Fracture of lower leg, including ankleFING000005554.02
1159Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T418ECGA0004184.02
1160Polyunsaturated fatty acids to total fatty acids percentageGCST905026454.02
1161SNX15 levelsGCST904706994.02
1162Current employment status - Doing unpaid or voluntary work | EmploymentUKBB000001574.01
1163LPCAT2 levelsGCST902418414.01
1164IDP dMRI TBSS ISOVF FornixGCST900044824.01
1165LY6D/PLA2G10 ratioGCST903153454.01
1166ESAM/TGFB1 ratioGCST903147184.00
1167IDP dMRI TBSS L3 Retrolenticular part of internal capsule RGCST900041914.00
1168IDP dMRI TBSS MD Pontine crossing tractGCST900040283.99
1169Ischemic heart disease (PheCode 411)GCST0083703.99
1170T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45)GCST903206083.99
1171IL1B levelsGCST904695703.98
1172PALM2 levelsGCST904701523.98
1173Macular cystFING000007433.98
1174BA-exvivo lh volume BA1GCST900028353.98
1175OCLN levelsGCST904701143.97
1176CD79B/FCRL2 ratioGCST903139003.97
1177Systolic blood pressure (UKB data field 4080)GCST904681793.96
1178Angina pectorisFING000000863.96
1179Skin yellow/blue componentGCST903202593.95
1180HeightGCST900259493.95
1181PSME2/RBKS ratioGCST903157373.95
1182Smoking dependencyFING000013153.95
1183Autorefraction - 3mm cylindrical power angle (left) | EyesightUKBB000000643.95
1184F9 levelsGCST904691723.95
1185Nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [LDH] (PheCode 573.6)GCST904760943.95
1186TNFRSF12A levelsGCST904709043.95
1187Triacylglycerol_49:3_[M+NH4]1+ levelsGCST900604433.94
1188IDP dMRI TBSS FA FornixGCST900038823.94
1189Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T401ECGA0004013.94
1190Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T77ECGA0000773.94
1191Familial combined hyperlipidemia defined by Brunzell criteriaGCST901040033.94
1192GSR levelsGCST904694103.94
1193PGF levelsGCST900119993.93
1194Hard cardiovascular diseasesFING000006023.93
1195Nonalcoholic fatty liver diseaseGCST902750413.92
1196BA-exvivo rh volume BA1GCST900028493.91
1197DLK1 levelsGCST904690033.91
1198wg lh intensity-contrast parsopercularisGCST900038093.91
1199AHCY/HSPA1A ratioGCST903132113.91
1200IDP dMRI ProbtrackX MD fmiGCST900042303.90
1201IDP dMRI TBSS ICVF Cingulum hippocampus RGCST900043633.90
1202Right-hemisphere limbic network to caudate white-matter structural connectivityGCST903028283.90
1203Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T30ECGU0000303.90
1204Aplastic anemiaGCST900185743.90
1205Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T32ECGU0000323.90
1206OsteoarthritisGCST904681443.90
1207DTI TBSS L2 Anterior corona radiata LGCST903844993.89
1208DFFA levelsGCST904689873.89
1209Triacylglycerol (48:2) [NL-16:0] levelsGCST900251433.88
1210aparc-Desikan lh volume postcentralGCST900027893.88
1211CRH levelsGCST904688623.88
1212Sphingomyelin_42:3_[M+H]1+ levelsGCST900603993.87
1213MCAM levelsGCST904698703.87
1214T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 28)GCST903208473.86
1215PMVK levelsGCST904702723.86
1216Metabolonic lactone sulfate levelsGCST902002573.86
1217DNA methylation PhenoAge accelerationGCST900142923.86
1218Blood cell traits latent factor 20 (red cell)GCST905592623.86
1219CCDC80 levelsGCST904685623.86
1220SNCA levelsGCST904706943.86
1221CST6 levelsGCST904688963.85
1222wg lh intensity-contrast superiorfrontalGCST900038193.85
1223HSPG2/VASN ratioGCST903150943.85
1224Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T11ECGU0000113.85
1225CD74/LILRB4 ratioGCST903138943.84
1226CNST/ITGB1BP2 ratioGCST903141583.84
1227AAMDC levelsGCST904681863.84
1228DNAJB1/STIP1 ratioGCST903145133.84
1229Other hammer toe(s) (acquired)FING000010543.83
1230IDP dMRI ProbtrackX L1 ifo lGCST900042583.83
1231Left-hemisphere dorsal attention network to thalamus white-matter structural connectivityGCST903027013.83
1232Glaucoma | GlaucomaUKBB000002863.83
1233T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 23)GCST903208423.82
1234aseg rh intensity Lateral-VentricleGCST900037783.82
1235GGT5 levelsGCST904693373.82
1236Myocardial infarction (PheCode 411.2)GCST904759323.81
1237OsteoarthritisGCST901342793.81
1238T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 127)GCST903206903.81
1239DTI TBSS FA Posterior limb of internal capsule RGCST903843983.81
1240IDP dMRI TBSS L3 Superior fronto-occipital fasciculus RGCST900042133.81
1241ALKBH3 levelsGCST906190953.80
1242NCK2/PLA2G4A ratioGCST903155243.80
1243Microscopic colitisGCST902041443.80
1244Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T25ECGA0000253.79
1245aparc-a2009s rh thickness G-postcentralGCST900037043.79
1246STK11 levelsGCST904707653.79
1247Fracture of rib(s), sternum and thoracic spineFING000005583.79
1248aseg rh volume PutamenGCST900026393.79
1249CNTN5 levelsGCST904688073.78
1250NOTCH3/PTPRS ratioGCST903155473.77
1251Bioavailable testosterone levelsGCST900121023.77
1252Barrett's esophagus or Esophageal adenocarcinomaGCST0037403.77
1253Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T234ECGA0002343.77
1254IDP dMRI ProbtrackX L3 ar rGCST900043013.76
1255Early lumbar disc prolapse, operatedFING000004843.76
1256Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T398ECGA0003983.76
1257Left ventricular wall thickness (mean)GCST904352643.76
1258MYOC/NOTCH3 ratioGCST903155073.75
1259Total testosterone levelsGCST902398203.75
1260ADAMTS8/FAP ratioGCST903131723.75
1261IDP dMRI TBSS FA Tapetum LGCST900039243.75
1262Left ventricular end diastole inferior wall thicknessGCST902785153.75
1263T1 FreeSurfer aseg 4th-VentricleGCST903841483.74
1264aparc-a2009s lh area S-subparietalGCST900033673.74
1265ANPEP/DPP4 ratioGCST903132733.74
1266KDR/VWF ratioGCST903152453.74
1267Retinal arteriolar tortuosityGCST902703973.74
1268wg lh intensity-contrast entorhinalGCST900037973.73
1269Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T374ECGU0003743.73
1270Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T400ECGA0004003.73
1271ADGRE5/NOTCH1 ratioGCST903131813.73
1272Ischemic Heart Disease | circulatory systemUKBB000003813.73
1273Enteritis due to Yersinia enterocoliticaFING000005053.73
1274FKBP1B levelsGCST904692423.72
1275Ceramide (d18:2/22:0) levelsGCST900246823.72
1276DPP6 levelsGCST904690343.72
1277Osteoporosis | musculoskeletalUKBB000005983.72
1278ASAH2 levelsGCST902420983.72
1279FABP4 levelsGCST900120753.71
1280Other disorders of veinsFING000010403.71
1281IDP dMRI TBSS MD Cingulum hippocampus RGCST900040633.71
1282aparc-Desikan rh area pericalcarineGCST900031273.71
1283Spherical power (left) | AutorefractionUKBB000007903.71
1284Osteoporosis NOS | musculoskeletalUKBB000005993.71
1285Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T368ECGU0003683.71
1286HJV levelsGCST904694553.71
1287TNFSF11 levelsGCST900120443.71
1288T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6)GCST903208253.70
1289aparc-a2009s rh area G-oc-temp-med-LingualGCST900033923.70
1290ASGR1/GGT5 ratioGCST903133653.70
1291Presence of cardiac and vascular implants and grafts | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000007083.70
1292IDP dMRI TBSS L2 Retrolenticular part of internal capsule LGCST900041443.70
1293Total protein levelsGCST900187563.69
1294IDP dMRI ProbtrackX FA ifo rGCST900039383.69
1295Diastolic blood pressure (UKB data field 4079)GCST904681633.69
1296Myocardial infarctionGCST900186573.68
1297RNASEH2A levelsGCST904704803.68
1298IDP dMRI ProbtrackX L2 fmaGCST900042833.67
1299MED18/SMAD1 ratioGCST903154133.67
1300Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T28ECGU0000283.67
1301Non-cancer illness code, self-reported - migraine | Medical conditionsUKBB000005203.66
1302DTI TBSS L3 Anterior corona radiata LGCST903845473.66
1303GPA33 levelsGCST904693853.66
1304CNTN4 levelsGCST904688063.66
1305aparc-a2009s lh volume G-cingul-Post-ventralGCST900029343.65
1306IDP T1 FAST ROIs R intracalc cortexGCST900024983.65
1307Heart valve disorders (PheCode 395)GCST904759133.65
1308FLI1 levelsGCST904692473.65
1309T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 50)GCST903206133.65
1310Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T364ECGU0003643.65
1311Hemangioma of skin and subcutaneous tissue (PheCode 228.1)GCST904756333.65
1312DIABLO/PRKAR1A ratioGCST903144693.65
1313Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levelsGCST900602803.64
1314HNRNPUL1 levelsGCST904694703.64
1315Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T34ECGU0000343.64
1316COL3A1 levelsGCST904688173.64
1317N-acetylglycine levelsGCST902435613.64
1318ATXN10/SLC27A4 ratioGCST903133993.64
1319DBH levelsGCST904689483.63
1320Polyp of the female genital tractFING000011903.62
1321Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T18ECGA0000183.62
1322Diseases of external earFING000004243.62
1323IDP dMRI ProbtrackX MD cst lGCST900042273.62
1324LEPR/NTRK2 ratioGCST903153133.62
1325SESTD1 levelsGCST904706043.61
1326DTI TBSS L1 Splenium of corpus callosumGCST903844323.61
1327ACVRL1/TNFRSF19 ratioGCST903131593.61
1328aseg global intensity WM-hypointensitiesGCST900037563.60
1329Fracture of lower limb | injuries & poisoningsUKBB000002553.60
1330T1 FreeSurfer a2009s lh G precentral volumeGCST903848443.60
1331IDP dMRI ProbtrackX FA ilf rGCST900039403.60
1332Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T231ECGA0002313.60
1333Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T421ECGA0004213.59
1334BAX levelsGCST904684243.59
1335aparc-DKTatlas rh thickness cuneusGCST900035743.59
1336Hair/balding pattern: Pattern 1 (UKB data field 2395_1)GCST900436163.58
1337Operative procedures - Haemorrhoidectomy | Summary OperationsUKBB000005803.58
1338SLC39A5 levelsGCST904706613.58
1339ALB levelsGCST900259923.58
1340Autorefraction - 6mm asymmetry angle (left) | EyesightUKBB000000723.58
1341Coronary artery bypass graftingFING000003583.58
1342APP/CD40LG ratioGCST903133193.58
1343DPT levelsGCST904690363.57
1344IDP dMRI ProbtrackX L2 ar rGCST900042743.57
1345Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T370ECGU0003703.57
1346wg lh intensity-contrast banksstsGCST900037933.57
1347Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T45ECGU0000453.57
1348Medication use (agents acting on the renin-angiotensin system)GCST900187683.57
1349AKR1B1 levelsGCST904682733.57
1350HHEX levelsGCST904694513.57
1351Dihexosylceramide (d18:1/22:0) levelsGCST900253483.56
1352Other disorders of eyelidFING000010263.56
1353IDP dMRI TBSS OD Superior corona radiata RGCST900044263.56
1354BA-exvivo lh area V1GCST900032163.55
1355Pulmonary tuberculosisGCST900186723.55
1356ITGA11 levelsGCST904696333.54
1357CREG1/NAAA ratioGCST903142503.54
1358PSAP levelsGCST904703513.53
1359Acetabular diameterGCST904489063.53
1360Osteomyelitis (PheCode 710.1)GCST904762213.52
1361DTI TBSS L3 Anterior corona radiata RGCST903845463.52
1362Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T72ECGU0000723.52
1363Operative procedures - Carpal tunnel release | Summary OperationsUKBB000005743.52
1364GDNF levelsGCST904693233.52
1365Forced expiratory volume (baseline)GCST905658443.51
1366Unspecified osteomyelitis (PheCode 710.19)GCST904762243.51
1367TBC1D5 levelsGCST904708113.51
1368IDP dMRI TBSS L2 Posterior corona radiata RGCST900041493.51
1369T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 107)GCST903206703.51
1370Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T27ECGU0000273.50
1371BA-exvivo rh area V2GCST900032313.50
1372IDP dMRI TBSS FA Tapetum RGCST900039233.50
1373Triacylglycerol_50:4_[M+NH4]1+ levelsGCST900604663.50
1374Rectal cancerGCST900118103.50
1375IDP T2 FLAIR BIANCA WMH volumeGCST900038623.50
1376CFB levelsGCST902407783.49
1377MTIF3 levelsGCST904699573.49
1378GFRA1 levelsGCST904693283.48
1379Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T376ECGU0003763.48
1380aseg lh intensity Accumbens-areaGCST900037743.48
1381Hernia abdominopelvic cavityGCST900860873.48
1382SEL1L levelsGCST904705643.48
1383T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 98)GCST903206613.47
1384Aneurysm of iliac artery (PheCode 442.2)GCST904759953.47
1385Glomerular filtration rate (cystatin C)GCST0033753.47
1386Humerus length to body height ratioGCST902702593.47
1387MEGF9 levelsGCST904698843.47
1388Cholesteryl ester_18:0_[M+NH4]1+ levelsGCST900602223.47
1389ADAMTS8 levelsGCST904682273.46
1390TNFRSF11B levelsGCST902431583.46
1391CLEC1B/MGLL ratioGCST903140973.46
1392Right-hemisphere visual network to accumbens white-matter structural connectivityGCST903027873.46
1393aparc-DKTatlas rh volume parstriangularisGCST900029113.46
1394PTPRZ1 levelsGCST904703883.45
1395AIFM1/PLXNA4 ratioGCST903132203.45
1396IDP dMRI TBSS MO Retrolenticular part of internal capsule RGCST900039723.45
1397IDP dMRI TBSS MO FornixGCST900039573.44
1398Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T379ECGU0003793.44
1399MSRA/P4HB ratioGCST903154953.43
1400Hippocampal subfield left CA3 volume (body)GCST902679403.42
1401TNFSF14 levelsGCST902748423.42
1402Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T378ECGU0003783.41
1403wg rh intensity-contrast parsorbitalisGCST900038453.41
1404Breast cancerGCST0100983.41
1405CACNB3 levelsGCST904685233.41
1406HydrocephalusFING000006283.40
1407IDP dMRI TBSS L2 Tapetum LGCST900041703.40
1408Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T236ECGA0002363.40
140910-undecenoate (11:1n1) levelsGCST902435963.40
1410Microalbumin urineGCST902786393.40
1411CTSZ/NAAA ratioGCST903143203.40
1412Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T46ECGU0000463.39
1413CDKN1A/TBL1X ratioGCST903139773.39
1414triglyceride (minimum, inv-norm transformed)GCST904764393.39
1415Paroxysmal tachycardiaFING000011513.39
1416BAMBI levelsGCST904684203.38
1417PI16 levelsGCST904702293.38
1418Liver volume (adjusted for height)GCST905668193.38
1419IDP dMRI ProbtrackX ICVF unc lGCST900044003.37
1420End-diastolic bi-ventricular shape (principal component 3)GCST904484823.37
1421ThalamNuclei lh volume CeMGCST900027253.37
1422Non-seminoma of testis, excluding all cancers (controls excluding all cancers)FING000008743.37
1423Benign leiomyoma with endometriosis (controls excluding all cancers)FING000001453.36
1424wg rh intensity-contrast parsopercularisGCST900038443.36
1425Disorders of iris and ciliary body (PheCode 379.5)GCST904758993.36
1426Sphingomyelin_41:0_[M+H]1+ levelsGCST900603863.36
1427IDP dMRI ProbtrackX ICVF cgh lGCST900043813.36
1428Systolic blood pressureGCST900187523.35
1429IDP dMRI ProbtrackX MD cgc lGCST900042233.35
1430Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T14ECGU0000143.35
1431aseg lh volume CaudateGCST900026213.35
1432Myocardial infarction (PheCode 411.2)GCST900439543.35
1433T1 CAT volume Vermis VIIIaGCST903841283.35
1434IDP dMRI TBSS MD Superior longitudinal fasciculus LGCST900040683.34
1435Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T45ECGA0000453.34
1436ELAC1 levelsGCST904691013.34
1437GRAP2/SNX9 ratioGCST903149883.34
1438CIAPIN1/SNAP29 ratioGCST903140673.33
1439SNAP29/SNX9 ratioGCST903158593.33
1440Spondylolisthesis/SpondylolysisFING000013243.32
1441triglyceride (maximum, inv-norm transformed)GCST904764313.32
1442Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T106ECGA0001063.32
1443CD40LG/EREG ratioGCST903138203.31
1444Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T67ECGU0000673.31
1445Systolic blood pressureGCST903016963.30
1446Prescriptions - amlodipine | calcium channel blocker,dihydropyridine,anti-hypertensiveUKBB000006603.30
1447KIAA0040 levelsGCST904225523.29
1448aparc-DKTatlas lh volume caudalmiddlefrontalGCST900028643.29
1449aparc-a2009s rh area S-calcarineGCST900034143.29
1450MUC16 levelsGCST904699643.29
1451IDP dMRI TBSS L3 Retrolenticular part of internal capsule LGCST900041923.29
1452Osteoporosis, osteopenia and pathological fracture | musculoskeletalUKBB000006003.29
1453Other menopausal disordersFING000010713.28
1454SMAD1 levelsGCST904706753.27
1455TBCA levelsGCST904708123.27
1456BTN2A1/SMOC2 ratioGCST903135493.27
1457CA1/TGM2 ratioGCST903135753.27
1458Other intervertebral disc disordersFING000010633.27
1459Volume of left accessory basal nucleusGCST904749403.27
1460Varicose veins of lower extremities | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classifiedUKBB000008943.27
1461OLR1/PLAUR ratioGCST903155843.27
1462Thoracic or lumbosacral neuritis or radiculitis, unspecified (PheCode 763)GCST904762683.27
1463aparc-DKTatlas rh area pericalcarineGCST900032843.27
1464SRSF7 levelsGCST902427713.26
1465T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 83)GCST903206463.26
1466End-diastolic bi-ventricular shape (principal component 9)GCST904484883.26
1467PRTG levelsGCST904703473.26
1468aparc-a2009s rh volume S-orbital-H-ShapedGCST900030623.26
1469aparc-DKTatlas rh thickness transversetemporalGCST900036013.26
1470DNER levelsGCST904690193.26
1471BA-exvivo lh volume V2GCST900028453.25
1472T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 104)GCST903206673.25
1473Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025803.24
1474BSG/LAMP3 ratioGCST903135333.24
1475Temporomandibular joint disorders, including avohilmoFING000013553.24
1476triglyceride (mean, inv-norm transformed)GCST904764353.23
1477IDP dMRI TBSS L1 Corticospinal tract RGCST900040813.23
1478BA-exvivo lh thickness V2GCST900035233.23
1479Illnesses of mother - High blood pressure | Family historyUKBB000003483.23
1480Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T68ECGU0000683.23
1481AOC3/ITGB1 ratioGCST903132953.23
1482IDP dMRI TBSS ICVF FornixGCST900043323.21
1483Triacylglycerol_48:3_[M+NH4]1+ levelsGCST900604183.21
1484REN levelsGCST904704543.21
1485wg rh intensity-contrast frontalpoleGCST900038583.20
1486ESAM levelsGCST904691523.20
1487LTA/LTBR ratioGCST903153363.20
1488ANPEP levelsGCST904683133.20
1489CX3CL1 levelsGCST902747783.19
1490Sphingomyelin_40:0_[M+H]1+ levelsGCST900603643.19
1491PTGES2 levelsGCST904703693.19
1492MIA levelsGCST904699033.19
1493Right-hemisphere somatomotor network to putamen white-matter structural connectivityGCST903027963.19
1494DNAJB1/EIF4B ratioGCST903145083.19
1495HippSubfield lh volume GC-ML-DG-bodyGCST900026813.19
1496Unspecified monoarthritis | musculoskeletalUKBB000008823.18
1497Autorefraction - 3mm weak meridian angle (left) | EyesightUKBB000000713.18
1498ATP5IF1/LYN ratioGCST903133893.18
1499APP/NID2 ratioGCST903133273.18
1500CD40/GLOD4 ratioGCST903138143.17
1501Skin red/green componentGCST903202583.17
1502NOS3 levelsGCST904700643.17
1503FSTL1 levelsGCST904692713.17
1504PILRA levelsGCST904702363.17
1505CHI3L1/HSPG2 ratioGCST903140433.17
1506Atherosclerosis (PheCode 440)GCST904759893.16
1507IDP dMRI ProbtrackX L3 fmaGCST900043103.16
1508IDP dMRI ProbtrackX L3 ar lGCST900043003.16
1509UFD1 levelsGCST904710053.15
1510red blood cell count (RBC, maximum, inv-norm transformed)GCST904763433.15
1511Cerebral aneurysm, nonrupturedFING000002633.14
1512Femoral herniaFING000005403.14
1513C3 levelsGCST902810413.14
1514CDH5 levelsGCST904686763.14
1515aparc-Desikan rh volume precentralGCST900028243.13
1516Left-hemisphere salience/ventral attention network to right-hemisphere somatomotor network white-matter structural connectivityGCST903027133.13
1517CardiomyopathyGCST903997053.13
1518T1 FreeSurfer BA rh V2 exvivo thicknessGCST903855713.12
1519Lung function (FEV1/FVC)GCST900259783.12
1520Systolic blood pressureGCST904727813.12
1521Adenocarcinoma and papilloma adenocarcinoma of rectumFING000000393.12
1522Chronic obstructive pulmonary diseaseGCST900185873.12
1523wg lh intensity-contrast fusiformGCST900037983.11
1524Right-hemisphere salience/ventral attention network to thalamus white-matter structural connectivityGCST903028173.11
1525Other peripheral nerve disorders (PheCode 351)GCST904758423.11
1526Volume of left cortical nucleusGCST904748863.11
1527Acylcarnitine (18:2) levelsGCST900246233.10
1528IL13RA1 levelsGCST904695523.10
1529Breast conditions, congenital or relating to hormones (PheCode 612)GCST904761623.10
1530BGLAP levelsGCST904684403.09
1531Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T238ECGA0002383.09
1532ECE1 levelsGCST904690613.09
1533Memory loss or impairmentGCST904755443.09
1534T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 36)GCST903205993.09
1535IDP dMRI TBSS L2 Retrolenticular part of internal capsule RGCST900041433.08
1536Diastolic blood pressureGCST903016993.08
1537Systolic blood pressure (MTAG)GCST904490563.08
1538Left-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivityGCST903027003.08
1539IDP dMRI TBSS MD Corticospinal tract RGCST900040333.08
1540CD300LG/DSG2 ratioGCST903138023.07
1541CA6 levelsGCST904685153.07
1542EGFLAM levelsGCST904216513.07
1543RBP7 levelsGCST904704403.07
1544Lysoalkylphosphatidylcholine (O-24:0) levelsGCST900248123.07
1545Pulse wave peak to peak time | Arterial stiffnessUKBB000007253.06
1546Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T397ECGA0003973.06
1547Female infertilityFING000005363.06
1548Endometriosis ASRM stages 3,4FING000004983.06
1549T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81)GCST903206443.06
1550Deep endometriosisFING000003823.06
1551SLC27A4 levelsGCST904706573.05
1552PRTFDC1 levelsGCST904703463.05
1553Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T23ECGU0000233.05
1554Isoleucine levels (UKB data field 23465)GCST902695623.05
1555CCL14 levelsGCST904685663.05
1556PCYT2 levelsGCST904701783.05
1557Omega-6 fatty acids to total fatty acids percentageGCST905025413.05
1558CNP levelsGCST904687983.04
1559CD244/FCRL6 ratioGCST903137653.04
1560aparc-Desikan rh thickness transversetemporalGCST900035113.03
1561T1 FreeSurfer aseg Right-Lateral-VentricleGCST903841573.03
1562IDP T1 FIRST right putamen volumeGCST900024413.03
1563Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T22ECGU0000223.03
1564LEPR levelsGCST904697563.02
1565Atrial septal defectFING000001283.02
1566DLK1/RGMB ratioGCST903144933.02
1567IDP dMRI ProbtrackX FA ar rGCST900039263.02
1568Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T101ECGA0001013.02
1569aparc-pial rh area lingualGCST900031863.02
1570aparc-Desikan lh volume caudalmiddlefrontalGCST900027713.02
1571Abdominal aortic calcification levelsGCST901346143.01
1572IDP T1 FAST ROIs R planum temporaleGCST900025423.01
1573Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)FING000003163.01
1574aparc-a2009s rh thickness G-cuneusGCST900036873.01
1575SpondylosisFING000013273.01
1576Omega-6 fatty acids to omega-3 fatty acids ratioGCST904991943.01
1577IDP dMRI TBSS L2 Superior corona radiata RGCST900041473.00
1578ESAM/FUT8 ratioGCST903147113.00
1579CCN3/PGF ratioGCST903137223.00
1580IDP dMRI TBSS L3 Superior fronto-occipital fasciculus LGCST900042143.00
1581Other disorders of corneaFING000010223.00
1582T1 FreeSurfer aseg 3rd-VentricleGCST903841472.99
1583Frozen shoulderGCST900005132.99
1584GADD45GIP1 levelsGCST904692932.99
1585SERPINA3 levelsGCST904705832.98
1586Triglyceride to HDL cholesterol ratioGCST902959492.98
1587AXL levelsGCST904684062.97
1588TSTA3 levelsGCST904218542.97
1589Female infertility, associated with anovulationFING000005372.97
1590BA-exvivo lh volume BA4pGCST900028402.97
1591Excessive hairinessGCST0060952.97
1592GFRA3 levelsGCST904693302.97
1593Docosahexaenoic acid levels (UKB data field 23450)GCST902695472.97
1594CPXM2 levelsGCST904688502.97
1595IL16 levelsGCST902415962.97
1596Pulse pressureGCST900187502.97
1597Isoleucine levelsGCST900928432.96
1598End-diastolic bi-ventricular shape (principal component 1)GCST904484802.96
1599Peripheral vascular diseaseGCST904759962.96
1600Phospholipids to total lipids ratio in large VLDLGCST900928772.95
1601Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+NH4]1+ levelsGCST900603032.95
1602Age-related macular degenerationGCST900861112.95
1603Diastolic blood pressureGCST904727772.95
1604Diastolic blood pressureGCST903102952.95
1605Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T237ECGA0002372.95
1606Hypoplasia of dental enamel, including avohilmoFING000006522.95
1607IDP dMRI TBSS ISOVF Superior longitudinal fasciculus LGCST900045182.94
1608MB levelsGCST900120472.94
1609Left-hemisphere limbic network to right-hemisphere limbic network white-matter structural connectivityGCST903027332.94
1610Prescriptions - calcium channel blocker|dihydropyridine|anti-hypertensiveUKBB000006732.94
1611Peripheral vascular disease, unspecified (PheCode 443.9)GCST904759982.94
1612GPI levelsGCST902412692.93
1613DYNLL1 levelsGCST902409842.93
1614Treatment speciality of consultant (recoded) - Cardiology | Summary AdministrationUKBB000008292.93
1615Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T44ECGA0000442.93
16161,2-dipalmitoyl-GPC (16:0/16:0) metabolite levelGCST906154382.93
1617Acetate levels (UKB data field 23475)GCST902695722.92
1618EGLN1/LSP1 ratioGCST903146172.92
16195-oxoproline levelsGCST902434372.91
1620CDH5/ENG ratioGCST903139542.91
1621Coronary heart diseaseGCST0009982.91
1622DNAJB1 levelsGCST904690122.91
1623Diastolic blood pressureGCST900259812.91
1624Noninflammatory disorders of female genital tractFING000008822.90
1625Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T107ECGA0001072.90
1626IGF1 levelsGCST904680782.90
1627Gamma-CEHC levelsGCST901998642.90
1628DNM1 levelsGCST904690212.89
1629aparc-DKTatlas lh volume postcentralGCST900028822.89
1630Familial combined hyperlipidemia defined by Mexico criteriaGCST901040072.89
1631IDP dMRI TBSS L3 Uncinate fasciculus RGCST900042152.88
1632PLA2G4A/PPP1R12A ratioGCST903156662.87
1633IRAK1 levelsGCST904696272.87
1634BLVRB/CA2 ratioGCST903135222.87
1635Total testosterone levelsGCST900121122.87
1636FNDC1 levelsGCST904692562.86
1637wg rh intensity-contrast superiorfrontalGCST900038542.86
16384-androsten-3beta,17beta-diol disulfate 2 levelsGCST902438802.86
1639NDUFB7 levelsGCST904700152.85
1640Calculus of lower urinary tractFING000002372.85
1641Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T422ECGA0004222.85
1642TNR levelsGCST904709292.85
1643Mandibular retrognathiaFING000007842.85
1644aparc-pial rh area parstriangularisGCST900031932.85
1645LGALS8/VWF ratioGCST903153222.85
1646End-diastolic bi-ventricular shape (principal component 10)GCST904484892.84
1647Inguinal herniaGCST900186482.84
1648IDP dMRI TBSS L3 Posterior thalamic radiation LGCST900042002.84
1649IDP dMRI ProbtrackX L2 ptr rGCST900042932.84
1650CardiomyopathyFING000002502.82
1651IDP dMRI TBSS L3 Posterior thalamic radiation RGCST900041992.82
1652Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T107ECGU0001072.82
1653Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T380ECGU0003802.82
1654Volume of right whole amygdalaGCST904749312.82
1655HPCAL1/MPIG6B ratioGCST903150732.81
1656Frequency of heavy DIY in last 4 weeks | Physical activityUKBB000002632.81
1657Birth weight | Early life factorsUKBB000000952.81
1658Mean bone marrow fat fraction of left and right proximal femurGCST906523942.80
1659Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T37ECGA0000372.80
1660ISLR2 levelsGCST904696292.80
1661IDP dMRI ProbtrackX FA fmiGCST900039362.80
1662CAPG levelsGCST904685372.80
1663Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T377ECGU0003772.80
1664Hippocampal right GC-ML-DG volume (head)GCST902679682.79
1665T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 93)GCST903209122.78
1666Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000001782.78
1667IDP dMRI TBSS L2 Posterior limb of internal capsule RGCST900041412.78
1668Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T363ECGU0003632.78
1669LTBR levelsGCST902431762.78
1670DTI TBSS MD Uncinate fasciculus RGCST903846162.78
1671OsteoporosisGCST900861222.78
1672Saturated fatty acids to total fatty acids percentageGCST905022052.77
1673STAT5B levelsGCST904707592.76
1674CD300LG levelsGCST904686232.76
1675Chronic rhinitis, nasopharyngitis and pharyngitisFING000002972.75
1676DOK2/PDLIM7 ratioGCST903145352.75
1677Fracture at wrist and hand levelFING000005512.75
1678Mononeuropathies of upper limb | Nerve, nerve root and plexus disordersUKBB000004812.75
1679CD40LG/SERPINE1 ratioGCST903138262.75
1680NAAA/SMPD1 ratioGCST903155102.75
1681VPS4B levelsGCST904710472.74
1682SSH3 levelsGCST904707492.74
1683COMP/THBS4 ratioGCST903141932.74
1684BCAM/CDH5 ratioGCST903134692.74
1685NCR3 levelsGCST900881792.74
1686ATXN2L levelsGCST904684022.73
1687Diastolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000001742.73
1688EIF4E levelsGCST904690962.73
1689IRF2 levelsGCST902415662.73
1690QC tfMRI-to-T1 linear alignment discrepancyGCST900063542.73
1691Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T23ECGA0000232.73
1692Epstein-Barr virus EA-D antibody levelsGCST900068982.72
1693Ascending aorta diameterGCST902673902.72
1694aparc-pial lh area pericalcarineGCST900031612.72
1695Shoulder width to body height ratioGCST902702612.72
1696WIF1 levelsGCST904710782.72
1697BA-exvivo rh thickness BA3bGCST900035302.72
1698aparc-Desikan rh thickness cuneusGCST900034832.72
1699Medication use (antiglaucoma preparations and miotics)GCST900187822.72
1700SPTLC1 levelsGCST904271302.71
1701ORM1 levelsGCST904701292.71
1702Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000001792.71
1703APRT/NSFL1C ratioGCST903133372.71
1704GPHA2 levelsGCST904693892.71
1705F3 levelsGCST904691702.71
1706PLA2G4A/SNAP29 ratioGCST903156692.71
1707Benign neoplasm: ChoroidFING000001702.71
1708SCLY/SORD ratioGCST903158162.71
1709Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T51ECGU0000512.71
1710T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 110)GCST903209292.71
1711Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T18ECGU0000182.71
1712RND3 levelsGCST906180662.71
1713EPS8L2 levelsGCST904691382.70
1714Colorectal cancer, excluding all cancers (controls excluding all cancers)FING000003172.70
1715Prescriptions - thiazide diuretic|diureticUKBB000007042.70
1716Varicose veins | circulatory systemUKBB000008932.70
1717DNER levelsGCST902747852.70
1718Left-hemisphere dorsal attention network to left-hemisphere default mode network white-matter structural connectivityGCST903026932.70
1719ERN1 levelsGCST904691482.70
1720DTI TBSS FA Superior longitudinal fasciculus LGCST903844212.70
1721Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T31ECGU0000312.70
1722Right-hemisphere control network to putamen white-matter structural connectivityGCST903028382.70
1723DTI TBSS L1 FornixGCST903844332.70
1724PPT1 levelsGCST904277182.69
1725Diastolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000001752.69
1726Triacylglycerol_50:3_[M+NH4]1+ levelsGCST900604682.69
1727IDP dMRI ProbtrackX L1 ilf lGCST900042602.69
1728LONP1 levelsGCST904697852.69
1729IDP dMRI TBSS MO Superior corona radiata RGCST900039762.69
1730Polyunsaturated fatty acids to total fatty acids percentageGCST905021792.69
1731T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 102)GCST903209212.69
1732Varicose veinsFING000014162.69
1733Hammer toe (acquired) (PheCode 735.21)GCST904762502.69
1734FCRLB levelsGCST904692102.69
1735DLL4 levelsGCST904690052.68
1736Modified Stumvoll Insulin Sensitivity Index (adjusted for BMI)GCST902675732.68
1737IDP dMRI ProbtrackX MD ptr lGCST900042382.68
1738Systolic blood pressureGCST900259682.67
1739Leucine levelsGCST902434052.67
1740HMCN2 levelsGCST904694612.67
1741Phosphatidylcholine diacyl C38:3 levelsGCST902400452.67
1742Tyrosine levelsGCST902434252.67
1743GLRX5 levelsGCST904693612.66
1744Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T64ECGU0000642.66
1745Osteoarthrosis | musculoskeletalUKBB000005962.66
1746HYOU1/THBD ratioGCST903151062.66
1747ASGR1 levelsGCST904683752.66
1748Prescriptions - bendroflumethiazide | thiazide diuretic,diureticUKBB000006672.66
1749Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)FING000000412.65
1750AHNAK2 levelsGCST904682602.65
1751Pregnenetriol disulfate levelsGCST902002382.65
1752Left ventricle sphericity indexGCST902684022.65
1753IDP dMRI TBSS ISOVF Posterior corona radiata LGCST900045042.65
1754Systolic blood pressure (BMI adjusted)GCST903351632.65
1755rfMRI connectivity (ICA100 edge 383)GCST900052362.64
1756Dry age-related macular degeneration (includes geographic atrophy)FING000004802.64
1757GORASP2 levelsGCST904693782.64
1758SFRP4 levelsGCST904706112.64
1759BA-exvivo rh volume BA6GCST900028552.64
1760IGFBP6/PTGDS ratioGCST903151372.64
1761Retinal vascular disordersFING000012622.64
1762Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T423ECGA0004232.64
1763Phospholipids to total lipids in large VLDL percentage (UKB data field 23589)GCST902696862.63
1764Knee osteoarthritisGCST0070902.63
1765IDP dMRI ProbtrackX FA unc lGCST900039502.63
1766FABP4 levelsGCST904691762.63
1767Phospholipids in large VLDLGCST904982472.63
1768DIABLO/VSIR ratioGCST903144702.63
1769GGH/INHBC ratioGCST903149282.62
1770aparc-a2009s rh thickness Pole-occipitalGCST900037182.62
1771DTI TBSS MD Tapetum LGCST903846192.62
1772Polyunsaturated fatty acids to total fatty acids percentage (UKB data field 23453)GCST902695502.62
1773IDP dMRI TBSS MD Anterior limb of internal capsule LGCST900040442.62
1774CDH5/PCDH17 ratioGCST903139582.62
1775Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T371ECGU0003712.62
1776aparc-pial lh area caudalmiddlefrontalGCST900031442.62
1777aparc-Desikan rh area parsopercularisGCST900031242.61
1778ANKRD54 levelsGCST904683112.61
1779X-21471 levelsGCST902005862.61
1780Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T229ECGA0002292.61
1781EndometriosisFING000004972.61
1782UBE2L6 levelsGCST904710012.60
1783T1 FreeSurfer DK lh lingual thicknessGCST903856342.60
1784BLVRB/HAGH ratioGCST903135242.59
1785CD27/FCRL5 ratioGCST903137722.59
1786aparc-Desikan rh thickness GlobalMeanThicknessGCST900034792.59
1787GLB1/IMPA1 ratioGCST903149322.59
1788aparc-a2009s rh area S-collat-transv-antGCST900034202.59
1789Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T22ECGA0000222.59
1790Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T50ECGU0000502.59
1791SCARA5/SCARF2 ratioGCST903158082.59
1792Liver volumeGCST905668182.58
1793Nonalcoholic fatty liver diseaseGCST900910332.58
1794wg rh intensity-contrast superiortemporalGCST900038562.58
1795RSPO3 levelsGCST904705042.58
1796IDP dMRI ProbtrackX ISOVF ilf lGCST900045392.58
1797RAPGEF2 levelsGCST904704262.58
1798NUB1 levelsGCST904700992.57
1799TGFBR3 levelsGCST904708482.57
1800Falls/tendency to fallFING000005302.57
1801Triacylglycerol (54:0) [NL-18:0] levelsGCST900251732.57
1802CD300E/CXCL10 ratioGCST903137962.57
1803Volume of left lateral nucleusGCST904749702.57
1804EFNA1 levelsGCST904690802.57
1805RBPMS2 levelsGCST904704412.56
1806DCTN6 levelsGCST904689602.56
1807Diastolic blood pressure (BMI adjusted)GCST903351652.56
1808MYOC levelsGCST904699832.55
1809Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T15ECGU0000152.55
1810Trigger fingerFING000013762.55
1811IDP T1 FAST ROIs L cerebellum I-IVGCST900025622.54
1812Breast cancerGCST900185792.54
1813ADGRE5/GAS6 ratioGCST903131792.54
1814ITGB5 levelsGCST904696452.54
1815N-acetylmethionine levelsGCST902002892.54
1816Height (weighted GWA)GCST902672852.54
1817ACVRL1/TNFRSF9 ratioGCST903131602.53
1818LDLRAP1 levelsGCST904697492.53
1819T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101)GCST903209202.53
1820CALCA levelsGCST904685282.53
1821THBS2 levelsGCST904708542.53
1822GLA levelsGCST904693542.53
1823PTRHD1 levelsGCST904703892.53
1824Acne (PheCode 706.1)GCST904762112.53
1825Right-hemisphere dorsal attention network to hippocampus white-matter structural connectivityGCST903028102.53
1826Mean arterial pressureGCST900187432.53
1827Lactate levelsGCST900928822.52
1828Cryptic phenotype that captures autosomal dominant polycystic kidney disease severityGCST901018292.52
1829LAG3/VCAM1 ratioGCST903152702.52
1830IDP dMRI TBSS MD Uncinate fasciculus RGCST900040712.52
1831Sciatica+with lumbagoFING000012792.52
1832RUVBL1 levelsGCST904705092.52
1833CD99L2 levelsGCST904686572.52
1834ThalamNuclei rh volume VAmcGCST900027472.51
1835Kynurenine levelsGCST902434772.51
1836Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T225ECGU0002252.51
1837Liver proton density fat fractionGCST902673522.51
1838T1 FreeSurfer a2009s rh G&S subcentral volumeGCST903850412.51
1839Late-onset myasthenia gravisGCST904321582.51
1840IDP dMRI TBSS L1 Cingulum hippocampus RGCST900041112.51
1841AHCY/FABP5 ratioGCST903132082.50
1842CA2/HMBS ratioGCST903135792.50
1843Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T35ECGA0000352.50
1844MTSS1 levelsGCST904699602.50
1845Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T303ECGU0003032.50
1846MECR levelsGCST904698792.50
1847CD69/PPP1R2 ratioGCST903138822.50
1848PLG levelsGCST904702572.49
1849SORD levelsGCST904707092.49
1850MSR1 levelsGCST904699502.49
1851Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T396ECGA0003962.49
1852F7/VASN ratioGCST903147452.49
1853GERD | digestiveUKBB000002832.49
1854TMPRSS11D levelsGCST904708912.49
1855Triacylglycerol_56:6_[M+NH4]1+ levelsGCST900605532.48
1856HippSubfield rh volume CA3-headGCST900027072.48
1857T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125)GCST903209442.48
1858Colitis, primary sclerosing, strict definitionFING000003132.48
1859Glaucoma, exfoliationFING000005802.48
1860LACTB2 levelsGCST904697262.48
1861Main speciality of consultant (recoded) - Cardiology | Summary AdministrationUKBB000004142.48
1862PHYKPL levelsGCST904702282.48
1863CES1 levelsGCST904687182.48
1864Low hand grip strength (60 years and older) (EWGSOP)GCST900075282.48
1865Pain and other conditions associated with female genital organs and menstrual cycleFING000011362.48
1866IDP dMRI ProbtrackX L2 cst rGCST900042822.48
1867NSFL1C/RILP ratioGCST903155602.48
1868RGCC levelsGCST904704612.47
1869Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T372ECGU0003722.47
1870aparc-pial lh area cuneusGCST900031452.47
1871ANGPTL4 levelsGCST904683052.47
1872T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 87)GCST903209062.47
1873ADAMTSL4 levelsGCST904682292.47
1874Varicose veins (PheCode 454)GCST904760122.47
1875Parental longevity (father's attained age)GCST0067012.47
1876T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42)GCST903208612.46
1877Degree of unsaturationGCST905022312.46
1878KeratitisFING000007082.46
1879wg lh intensity-contrast temporalpoleGCST900038242.46
1880NRGN levelsGCST904700832.46
1881ICAM5 levelsGCST904695022.46
1882wg lh intensity-contrast inferiorparietalGCST900037992.46
1883FGF19 levelsGCST904692202.46
1884ITGA2 levelsGCST904696342.46
1885T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 44)GCST903206072.45
1886Cellulitis and abscess of leg, except foot (PheCode 681.5)GCST904761662.45
1887NT5C3A levelsGCST904700912.45
1888IGF1 levelsUKBB000003372.45
1889CELSR2 levelsGCST904687032.45
1890Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T104ECGU0001042.44
1891X-26109 levelsGCST902006712.44
1892BIRC2/CD40LG ratioGCST903135172.44
1893IDP dMRI ProbtrackX L1 cgh lGCST900042522.44
1894Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T17ECGA0000172.44
1895COL6A3/SPON2 ratioGCST903141792.44
1896aparc-pial rh area cuneusGCST900031782.44
1897AXIN1/IKBKG ratioGCST903134092.44
1898SHMT1 levelsGCST904706272.44
1899Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T19ECGA0000192.43
1900Left-hemisphere control network to accumbens white-matter structural connectivityGCST903027582.43
1901MANSC1/PODXL ratioGCST903153722.43
1902Forced expiratory volume in 1-second (FEV1) | SpirometryUKBB000002512.43
1903MTDH levelsGCST904699542.43
1904DTI autoptx L2 atr l tractGCST903851682.43
1905Chronic hepatitis B infectionGCST900185842.43
1906ERP29 levelsGCST900888432.43
1907ALB levelsGCST904971082.43
1908HSD11B1/SMPD1 ratioGCST903150822.42
1909BCAM levelsGCST904684252.42
1910Barrett's esophagusGCST900005152.42
1911Spinal stenosisFING000013222.42
1912MEGF9/MET ratioGCST903154182.42
1913IDP dMRI TBSS ICVF Cingulum hippocampus LGCST900043642.41
1914MOG/PTPRN2 ratioGCST903154752.41
1915Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T106ECGU0001062.41
1916CHAC2 levelsGCST904687362.41
1917ANG/F9 ratioGCST903132592.40
1918Disorders of ocular muscles, binocular movement, accommodation and refractionFING000004462.40
1919FLRT2 levelsGCST904692482.40
1920CR2 levelsGCST904688522.40
1921Left-hemisphere control network to putamen white-matter structural connectivityGCST903027542.40
1922Peak expiratory flow (UKB data field 3064)GCST904681762.40
1923T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 7)GCST903205702.39
1924aparc-DKTatlas lh area pericalcarineGCST900032532.39
1925CDH5/NOTCH1 ratioGCST903139572.39
1926Treatment/medication code - lansoprazole | MedicationsUKBB000008482.39
1927Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T17ECGU0000172.39
1928ANXA11 levelsGCST904683152.39
1929MIA/NBL1 ratioGCST903154452.38
1930CA5A/KRT18 ratioGCST903135922.38
1931PRKAR1A/SNAP23 ratioGCST903157282.38
1932PPIB levelsGCST904702912.37
1933UNC5D levelsGCST904710102.37
1934Vertical cup-disc ratioGCST0040752.37
1935MARS1 levelsGCST904698622.37
1936IDP dMRI TBSS L2 Superior fronto-occipital fasciculus LGCST900041662.37
1937Alanine transaminase (ALT, mean, inv-norm transformed)GCST904751122.37
1938Spherical power (right) | AutorefractionUKBB000007912.36
1939PDGFC/TFPI ratioGCST903156362.36
1940Volume of right paralaminar nucleusGCST904749282.36
1941PRAP1 levelsGCST904703122.36
1942ENAH levelsGCST904691062.36
1943Diastolic blood pressure (MTAG)GCST904490572.36
1944Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T24ECGA0000242.36
1945Gonarthrosis [arthrosis of knee] | ArthrosisUKBB000002902.36
1946DTI autoptx FA unc r tractGCST903851382.36
1947CLEC1A/TNFRSF1A ratioGCST903140852.36
1948diastolic blood pressure (DBP, maximum, inv-normal transformed)GCST904752522.36
1949STAT2 levelsGCST904707582.36
1950AKT2 levelsGCST904682772.35
1951IDP dMRI TBSS L2 Posterior thalamic radiation LGCST900041522.35
1952Redundant prepuce, phimosis and paraphimosisFING000012462.35
1953TWF2 levelsGCST904709872.35
1954CRIP2 levelsGCST904688642.35
1955GFRA1/SPON2 ratioGCST903149232.34
1956Testosterone levels (UKB data field 30850)GCST904681032.34
1957FABP2/RBP2 ratioGCST903147572.34
1958IDP dMRI ProbtrackX ICVF cgh rGCST900043822.34
1959COL15A1 levelsGCST904688112.34
1960GET3 levelsGCST904693242.34
1961Myocardial fractal dimension (slice 8)GCST900002942.34
1962SMAD2 levelsGCST904706762.34
1963SNX5 levelsGCST904707022.34
1964Aspartate aminotransferase | Blood biochemistryUKBB000000522.34
1965Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T184ECGU0001842.34
1966DKK4/REG1A ratioGCST903144892.33
1967Other diseases of the digestive systemFING000010102.33
1968Triacylglycerol_51:3_[M+NH4]1+ levelsGCST900604942.33
1969IDP dMRI TBSS MD Posterior thalamic radiation RGCST900040552.33
1970Diastolic blood pressureGCST903017002.32
1971FURIN/PLA2G15 ratioGCST903148872.32
1972STXBP1 levelsGCST904707772.32
1973Omega-6 fatty acids to total fatty acids percentageGCST905021272.32
1974SNX9/STIP1 ratioGCST903158642.32
1975SLC27A4/TDRKH ratioGCST903158512.32
1976Left-hemisphere somatomotor network to amygdala white-matter structural connectivityGCST903026872.31
1977Pain type(s) experienced in last month - Back pain | PainUKBB000006262.31
1978IDP dMRI ProbtrackX FA ifo lGCST900039372.31
1979ACP5 levelsGCST904682032.31
1980Ischemic strokeGCST900186442.31
1981BLMH/PEAR1 ratioGCST903135192.31
1982REG1A/REG4 ratioGCST903157622.31
1983CNPY4 levelsGCST904688002.31
1984aseg global intensity 4th-VentricleGCST900037522.31
1985IDP dMRI TBSS FA Sagittal stratum LGCST900039082.30
1986CCN3 levelsGCST902424922.30
1987PDAP1 levelsGCST904701792.30
1988MDH1 levelsGCST904698762.30
1989GPR37 levelsGCST904693972.30
1990Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T300ECGU0003002.30
1991RBP2 levelsGCST904704382.30
1992PCBP2 levelsGCST904701672.30
1993Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T373ECGU0003732.29
1994GRHPR levelsGCST904694002.29
1995MPO levelsGCST904699372.29
1996SNAP29/TJAP1 ratioGCST903158612.29
1997Pregnenediol disulfate (C21H34O8S2) levelsGCST901998402.29
1998Milk type used: Soy milk vs never have milk (UKB data field 1418)GCST901329432.28
1999HypertensionFING000006372.28
2000SELE levelsGCST904705662.28